Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018).

Cantón, R; Loza, E; Arcay, R M; Cercenado, E; Castillo, F J; Cisterna, R; Gálvez-Benítez, L; González Romo, F; Hernández-Cabezas, A; Rodríguez-Lozano, J; Suárez-Barrenechea, A I; Tubau, F; Díaz-Regañón, J; López-Mendoza, D

Cantón, R; Loza, E; Arcay, R M; Cercenado, E; Castillo, F J; Cisterna, R; Gálvez-Benítez, L; González Romo, F; Hernández-Cabezas, A; Rodríguez-Lozano, J; Suárez-Barrenechea, A I; Tubau, F; Díaz-Regañón, J; López-Mendoza, D.

Affiliation

Cantón R; Rafael Cantón, Servicio de Microbiología, Hospital Universitario Ramón y Cajal. Madrid. Carretera de Colmenar Km 9,1. 28034-Madrid. Spain. rafael.canton@salud.madrid.org.

Rev Esp Quimioter ; 34(3): 228-237, 2021 Jun.

Article in En | MEDLINE | ID: mdl-33645948

Subject(s)

Pseudomonas Infections; Pseudomonas aeruginosa; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Cephalosporins/pharmacology; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Pseudomonas Infections/drug therapy; Pseudomonas Infections/epidemiology; Spain/epidemiology; Tazobactam

Key words

Ceftolozane-tazobactam; Enterobacterales; Pseudomonas aeruginosa; surveillance study

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas aeruginosa / Pseudomonas Infections Limits: Humans Country/Region as subject: Europa Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google